학술논문
LBA47 A phase II study evaluating tipifarnib in mHRAS, recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) (AIM-HN study)
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S1286-S1287
Subject
Language
ISSN
0923-7534